Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients

• Status: Completed
• Trial end date: 2016-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the effectiveness of inhaled mometasone/formoterol versus inhaled fluticasone/salmeterol on peripheral airway function in treatment of asthma.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Fluticasone; Fluticasone Propionate, Salmeterol Xinafoate Drug Combination; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Mometasone Furoate; Salmeterol Xinafoate

Criteria

Inclusion Criteria:

1. Newly diagnosed asthma according to Global Initiative for Asthma (GINA) guideline 2014 without previous treatment of inhaled corticosteroid and long acting beta agonists

2. Patients with asthma symptoms of most days or wake up due to asthma one time per week or more

3. Patients with the presence of any risk factors of asthma according to Global Initiative for Asthma (GINA) guideline 2014

4. Patients with severe uncontrolled asthma

5. Patients with previous asthma exacerbation

6. Patients give consent form

Exclusion Criteria:

1. Patients with contra-indication for performing spirometry according to American Thoracic Society (ATS) and European Respiratory Society (ERS) statement of standardization for spirometry

2. Patients refuse to participate study -